+1,011.8%
MRNA vs RCAT
+0.4%
+1,011.4%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | RCAT | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.9% | -31.7% | +27.8% | -3.4% |
| 7D | -17.6% | -42.8% | +25.2% | -16.8% |
| 30D | -5.1% | -48.9% | +43.8% | -4.1% |
| 3M | +220.8% | -76.9% | +297.7% | +228.4% |
| 6M | +321.7% | -74.6% | +396.3% | +330.2% |
| YTD | +601.3% | -69.6% | +670.9% | +612.0% |
| 1Y | +735.2% | -64.4% | +799.6% | +745.8% |
| 3Y | +170.5% | +173.9% | -3.3% | +165.4% |
| 5Y | -14.6% | -4.4% | -10.3% | -15.9% |
| All | +1,011.8% | +0.4% | +1,011.4% | +841.0% |
Cumulative growth
Daily Returns
Daily percentage return beside RCAT.
Daily Out/Under-Performance
Portfolio return minus RCAT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RCAT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded RCAT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling